| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 16 | 2023 | 455 | 2.360 |
Why?
|
| Echocardiography, Doppler | 10 | 2018 | 131 | 1.410 |
Why?
|
| Heart Ventricles | 13 | 2023 | 250 | 1.340 |
Why?
|
| Ventricular Function, Left | 10 | 2019 | 262 | 1.230 |
Why?
|
| Ventricular Dysfunction, Left | 11 | 2020 | 160 | 1.220 |
Why?
|
| Sepsis | 2 | 2019 | 280 | 0.960 |
Why?
|
| Electrocardiography | 10 | 2019 | 523 | 0.950 |
Why?
|
| Head and Neck Neoplasms | 2 | 2016 | 153 | 0.910 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2017 | 47 | 0.880 |
Why?
|
| Stroke Volume | 11 | 2018 | 317 | 0.870 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 233 | 0.860 |
Why?
|
| Echocardiography, Transesophageal | 10 | 2006 | 91 | 0.730 |
Why?
|
| Situs Inversus | 1 | 2019 | 5 | 0.660 |
Why?
|
| Dextrocardia | 1 | 2019 | 5 | 0.660 |
Why?
|
| Shock, Septic | 2 | 2019 | 90 | 0.610 |
Why?
|
| Aged | 43 | 2019 | 13292 | 0.600 |
Why?
|
| Pulmonary Embolism | 2 | 2017 | 169 | 0.600 |
Why?
|
| Systole | 7 | 2019 | 109 | 0.570 |
Why?
|
| Dilatation | 1 | 2016 | 29 | 0.550 |
Why?
|
| Medical Audit | 1 | 2016 | 60 | 0.540 |
Why?
|
| Humans | 70 | 2023 | 59324 | 0.540 |
Why?
|
| Hyperkalemia | 1 | 2016 | 23 | 0.540 |
Why?
|
| Risk Adjustment | 1 | 2016 | 91 | 0.530 |
Why?
|
| Pacemaker, Artificial | 2 | 2013 | 41 | 0.530 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 43 | 0.530 |
Why?
|
| Potassium | 1 | 2016 | 109 | 0.520 |
Why?
|
| Diastole | 7 | 2016 | 89 | 0.520 |
Why?
|
| Electroencephalography | 1 | 2016 | 136 | 0.510 |
Why?
|
| Female | 52 | 2020 | 30826 | 0.500 |
Why?
|
| Benchmarking | 1 | 2016 | 135 | 0.500 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2023 | 34 | 0.500 |
Why?
|
| Middle Aged | 37 | 2017 | 16235 | 0.490 |
Why?
|
| Heart Rate | 6 | 2012 | 304 | 0.480 |
Why?
|
| Male | 43 | 2019 | 27508 | 0.480 |
Why?
|
| Myocardial Infarction | 5 | 2015 | 855 | 0.470 |
Why?
|
| Takotsubo Cardiomyopathy | 4 | 2020 | 63 | 0.460 |
Why?
|
| Atrial Fibrillation | 4 | 2016 | 795 | 0.450 |
Why?
|
| Tracheostomy | 1 | 2014 | 32 | 0.450 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 119 | 0.440 |
Why?
|
| Heart Neoplasms | 5 | 2006 | 33 | 0.440 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2013 | 5 | 0.430 |
Why?
|
| Hepatic Veins | 1 | 2013 | 13 | 0.420 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 168 | 0.420 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1130 | 0.420 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 90 | 0.400 |
Why?
|
| Myocardial Contraction | 3 | 2009 | 83 | 0.390 |
Why?
|
| Algorithms | 2 | 2016 | 986 | 0.390 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 168 | 0.380 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 2009 | 11 | 0.380 |
Why?
|
| Heart Atria | 6 | 2023 | 137 | 0.360 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 354 | 0.360 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 152 | 0.360 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2010 | 244 | 0.360 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 16 | 0.350 |
Why?
|
| Aortic Valve | 4 | 2011 | 164 | 0.350 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2010 | 32 | 0.350 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 77 | 0.350 |
Why?
|
| Metoprolol | 1 | 2009 | 11 | 0.340 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2006 | 19 | 0.340 |
Why?
|
| Cardiac Catheterization | 4 | 2014 | 240 | 0.330 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 149 | 0.320 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2002 | 40 | 0.320 |
Why?
|
| Blood Pressure | 4 | 2010 | 519 | 0.310 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 202 | 0.310 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2008 | 24 | 0.310 |
Why?
|
| Cardiac Volume | 1 | 2007 | 7 | 0.300 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 1548 | 0.300 |
Why?
|
| Stress, Physiological | 2 | 2009 | 185 | 0.300 |
Why?
|
| Ventricular Function | 1 | 2007 | 21 | 0.290 |
Why?
|
| Heart Failure | 7 | 2016 | 861 | 0.280 |
Why?
|
| Electric Countershock | 3 | 2015 | 98 | 0.270 |
Why?
|
| Myxoma | 3 | 2006 | 14 | 0.270 |
Why?
|
| Sensitivity and Specificity | 7 | 2016 | 1093 | 0.260 |
Why?
|
| Heart Diseases | 3 | 2007 | 204 | 0.260 |
Why?
|
| Hypertension | 2 | 2009 | 600 | 0.260 |
Why?
|
| Acute Coronary Syndrome | 1 | 2009 | 256 | 0.260 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 191 | 0.250 |
Why?
|
| United Kingdom | 2 | 2016 | 69 | 0.250 |
Why?
|
| Stress, Psychological | 2 | 2009 | 443 | 0.250 |
Why?
|
| Retrospective Studies | 11 | 2018 | 5975 | 0.250 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 105 | 0.250 |
Why?
|
| Ventricular Remodeling | 3 | 2018 | 80 | 0.250 |
Why?
|
| Arrhythmia, Sinus | 1 | 2004 | 2 | 0.240 |
Why?
|
| Heart Block | 1 | 2004 | 23 | 0.240 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2012 | 122 | 0.240 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 21 | 0.240 |
Why?
|
| Triglycerides | 1 | 2005 | 242 | 0.230 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 5067 | 0.230 |
Why?
|
| Heart Valve Prosthesis | 2 | 2002 | 89 | 0.220 |
Why?
|
| Viridans Streptococci | 1 | 2002 | 5 | 0.210 |
Why?
|
| Adult | 16 | 2016 | 15733 | 0.200 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 77 | 0.200 |
Why?
|
| Coronary Angiography | 4 | 2010 | 168 | 0.200 |
Why?
|
| Abscess | 1 | 2002 | 74 | 0.200 |
Why?
|
| Chest Pain | 2 | 2019 | 85 | 0.180 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2000 | 8 | 0.180 |
Why?
|
| Collateral Circulation | 1 | 2000 | 22 | 0.180 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 5 | 0.180 |
Why?
|
| Risk Factors | 7 | 2016 | 4999 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2004 | 52 | 0.170 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 1999 | 2 | 0.170 |
Why?
|
| Lymphoma | 1 | 2000 | 98 | 0.170 |
Why?
|
| Heart Aneurysm | 1 | 1999 | 22 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 27 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 1999 | 45 | 0.160 |
Why?
|
| Heart Valves | 1 | 2018 | 22 | 0.160 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 100 | 0.160 |
Why?
|
| Abdominal Pain | 1 | 2019 | 92 | 0.160 |
Why?
|
| Mitral Valve | 3 | 2004 | 103 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2015 | 1907 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1999 | 74 | 0.160 |
Why?
|
| Aging | 2 | 2003 | 723 | 0.160 |
Why?
|
| Aortic Diseases | 2 | 2011 | 67 | 0.150 |
Why?
|
| Ultrasonography | 4 | 2009 | 449 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2016 | 5142 | 0.150 |
Why?
|
| Prognosis | 5 | 2009 | 1564 | 0.150 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 86 | 0.150 |
Why?
|
| Dobutamine | 2 | 1994 | 6 | 0.140 |
Why?
|
| Reference Values | 3 | 2007 | 323 | 0.140 |
Why?
|
| Massachusetts | 7 | 2016 | 2083 | 0.140 |
Why?
|
| Cough | 1 | 2019 | 182 | 0.140 |
Why?
|
| Thallium Radioisotopes | 3 | 1995 | 9 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2016 | 28 | 0.140 |
Why?
|
| Incidence | 3 | 2016 | 1232 | 0.130 |
Why?
|
| Catheterization | 1 | 1997 | 110 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 61 | 0.130 |
Why?
|
| Mitoxantrone | 1 | 2016 | 17 | 0.130 |
Why?
|
| ROC Curve | 1 | 2016 | 259 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 1996 | 31 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1997 | 50 | 0.130 |
Why?
|
| Mitral Valve Stenosis | 1 | 1995 | 11 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2016 | 919 | 0.120 |
Why?
|
| Machine Learning | 1 | 2016 | 135 | 0.120 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 4 | 0.120 |
Why?
|
| Bundle-Branch Block | 1 | 1994 | 14 | 0.120 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2014 | 18 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 114 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 36 | 0.120 |
Why?
|
| Tachycardia, Sinus | 1 | 1994 | 3 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 63 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 926 | 0.120 |
Why?
|
| Logistic Models | 2 | 2016 | 1252 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 301 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 55 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 63 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 85 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 163 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2015 | 136 | 0.110 |
Why?
|
| Prevalence | 4 | 2010 | 1279 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 242 | 0.110 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 73 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 450 | 0.100 |
Why?
|
| Device Removal | 1 | 2013 | 54 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 98 | 0.100 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 92 | 0.100 |
Why?
|
| Age Factors | 2 | 2014 | 1518 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1454 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2016 | 3095 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 257 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2009 | 2436 | 0.090 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 5 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2012 | 137 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 28 | 0.090 |
Why?
|
| Diclofenac | 1 | 2010 | 4 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2010 | 19 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2010 | 58 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 95 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 895 | 0.090 |
Why?
|
| Angiocardiography | 1 | 2009 | 6 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 281 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 111 | 0.080 |
Why?
|
| Disease Progression | 3 | 2008 | 1039 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2010 | 157 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2014 | 2323 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1061 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 241 | 0.080 |
Why?
|
| Syndrome | 2 | 2006 | 173 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2011 | 1311 | 0.080 |
Why?
|
| Contrast Media | 1 | 2010 | 408 | 0.070 |
Why?
|
| Conscious Sedation | 2 | 2004 | 50 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 810 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 201 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1024 | 0.070 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2006 | 4 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4320 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 124 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 30 | 0.060 |
Why?
|
| Magnetics | 1 | 2005 | 53 | 0.060 |
Why?
|
| Ventricular Pressure | 1 | 2005 | 30 | 0.060 |
Why?
|
| Patient Selection | 1 | 2007 | 445 | 0.060 |
Why?
|
| Time Factors | 3 | 2009 | 3567 | 0.060 |
Why?
|
| Inpatients | 1 | 2008 | 296 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 712 | 0.060 |
Why?
|
| Video Recording | 1 | 2005 | 125 | 0.060 |
Why?
|
| Exercise Test | 3 | 1995 | 233 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 69 | 0.060 |
Why?
|
| Adenosine | 2 | 1995 | 70 | 0.060 |
Why?
|
| Pericarditis, Constrictive | 1 | 2003 | 3 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2005 | 485 | 0.060 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2003 | 19 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2007 | 403 | 0.050 |
Why?
|
| Coronary Disease | 2 | 2003 | 249 | 0.050 |
Why?
|
| Pericardium | 1 | 2023 | 35 | 0.050 |
Why?
|
| Hemodynamics | 4 | 2003 | 232 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 99 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 959 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2002 | 26 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2000 | 42 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1135 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1995 | 116 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 1995 | 108 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2003 | 141 | 0.040 |
Why?
|
| Catheterization, Central Venous | 1 | 1998 | 85 | 0.030 |
Why?
|
| Myocardial Stunning | 1 | 1996 | 6 | 0.030 |
Why?
|
| Child | 2 | 2011 | 4300 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 50 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 77 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 56 | 0.030 |
Why?
|
| Electrodes | 1 | 1996 | 35 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2462 | 0.030 |
Why?
|
| Length of Stay | 2 | 2010 | 765 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 1448 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1994 | 74 | 0.030 |
Why?
|
| Perfusion | 1 | 1994 | 77 | 0.030 |
Why?
|
| Heart | 1 | 1996 | 274 | 0.030 |
Why?
|
| Linear Models | 1 | 1995 | 419 | 0.030 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 273 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 787 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2013 | 23 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1994 | 108 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2012 | 35 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 163 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1086 | 0.030 |
Why?
|
| Acute Disease | 1 | 1994 | 658 | 0.030 |
Why?
|
| Biomarkers | 2 | 2010 | 1205 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1992 | 61 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 576 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 643 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 121 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 165 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 99 | 0.020 |
Why?
|
| Oxygen | 1 | 1991 | 307 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 188 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 391 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 732 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 565 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 200 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 172 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2006 | 45 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 117 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 553 | 0.020 |
Why?
|
| Reoperation | 1 | 2006 | 249 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 266 | 0.020 |
Why?
|
| Midazolam | 1 | 2004 | 12 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 158 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 1995 | 32 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 2004 | 27 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 43 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 148 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 208 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2004 | 35 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 70 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 11 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2003 | 42 | 0.010 |
Why?
|
| Rhabdomyolysis | 1 | 2003 | 26 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 31 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 134 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 138 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 19 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 262 | 0.010 |
Why?
|
| Venae Cavae | 1 | 1998 | 2 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1998 | 34 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 150 | 0.010 |
Why?
|
| Thrombosis | 1 | 1998 | 195 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1995 | 73 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 300 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 403 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1994 | 4 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1994 | 36 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1994 | 52 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 672 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 170 | 0.010 |
Why?
|
| Forecasting | 1 | 1994 | 221 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1991 | 10 | 0.010 |
Why?
|
| Peritonitis | 1 | 1991 | 33 | 0.010 |
Why?
|
| Swine | 1 | 1991 | 338 | 0.010 |
Why?
|
| United States | 1 | 2003 | 7492 | 0.010 |
Why?
|
| Animals | 1 | 1991 | 19613 | 0.000 |
Why?
|